Oct 2026· Biosensors & bioelectronics· Vol 316, pp.
119360
· 0 citations· 26 references
Medicine
TL;DR
A CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA, enabling Mn2+-responsive control over its trans-cleavage activity for nucleic-acid-amplification-free detection and establishing a powerful platform for biosensing.
Abstract
CRISPR-Cas12a biosensing is hindered by insufficient sensitivity that necessitates pre-amplification, as well as the limited ability to directly detect non-nucleic-acid targets. Herein, we developed a CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA (e-crRNA), enabling Mn2+-responsive control over its trans-cleavage activity for nucleic-acid-amplification-free detection. Upon Mn2+-dependent activation, the DNAzyme cleaved the e-crRNA to liberate a full-sized crRNA1 and a split crRNA2. The combined crRNA1/crRNA2 system enhanced Cas12a trans-cleavage activity, compensating for the activity loss associated with crRNA engineering. Rational design of the split site further improved the signal-to-noise ratio. Moreover, by gating the system activation on Mn2+, the non-specific activation effects caused by spurious DNA hybridization were mitigated. When coupled with a Mn2+-responsive signal conversion strategy, this platform achieved sensitive detection of alkaline phosphatase with the LOD of 0.008 U/L and Staphylococcus aureus with the LOD of 29.76 CFU/mL. This study showcased the innovative use of Mn2+-dependent DNAzyme to efficiently activate CRISPR-Cas12a system, establishing a powerful platform for biosensing.
Staphylococcus aureus (S. aureus) is a major foodborne and clinical pathogen, and its rapid and accurate detection are essential for food safety monitoring and clinical diagnostics. Here, we developed a colorimetric platform for quantifying S. aureus that integrates circular DNA (Cir-DNA)-mediated Cas12a autocatalyti...
Yu Liu, Tian-Tian Chen, Ao-Feng Yang et al.· Analytical Chemistry· 0 citations
The CRISPR-Cas12a system has revolutionized molecular diagnostics; however, the strict requirement of crRNAs and target DNA for collateral cleavage activation restricts its flexibility in non-nucleic acid diagnostics. Herein, we demonstrate that AsCas12a exhibits an RNA-free collateral cleavage activity with the presen...
Shuai Wu, Jia-Lin Xu, Yan-Ting Sun et al.· ACS Sensors· 0 citations
The programmability of CRISPR-Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non-nucleic-acid targets remains highly desirable. Here, we report a universal split-activator strategy that enables programmable Cas12a activation in response to a small molecule and...
R. J. Tharu, Yusha Imtiaz, Shubhajit Singha et al.· Small Methods· 0 citations
Residual gene editors are a concern associated with the widespread application of CRISPR/Cas9 technology. Here, we developed a CRISPR/Cas12a-based fluorescent aptasensor for the qualitative and quantitative detection of Cas9 protein. Secondary structure prediction and molecular docking were combined to identify potenti...
Zi-Zhao Wang, Jing Wang, Ling Li et al.· Molecules· 0 citations
Rapid and sensitive detection of Staphylococcus aureus (S. aureus) is critical for food safety and public health. Herein, this work developed an ABC (aptamer-B-PER-CRISPR) cascade detection platform, where B-PER stands for bidirectional primer exchange reaction, that integrates aptamer-mediated target recognition, B-PE...
Jia-Lin Jiang, Yuan Peng, Wen-Jie Ma et al.· Analytical Methods· 0 citations
CRISPR/Cas12a diagnostics have greatly advanced nucleic acid testing, yet their extension to non-nucleic acid targets remains constrained by the intricate preamplification process and by inefficient signal transduction. Herein, we present a non-nucleic acid detection platform that integrates a CRISPR/Cas12a positive-fe...
Jian-Le Wang, Qiu-Yun Tian, Yu-Ling Li et al.· ACS Sensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.